Closing Out a Study

Part of Clinical Research Coordinator (CRC) Training: Monitoring, Close-Out and Your Career.

About 6 minutes. Free, in your language, no account needed.

Why this matters

Close-out is the part of the job nobody trains for and everybody underestimates. The participants have finished, the excitement has gone, and the person who ran the study has often moved on.

It is also the part an inspector is most likely to see, because inspections often happen after a study ends. What you leave behind is what your site will be judged on.

What close-out involves

Close-out is not a single event. It is a sequence.

1. Last participant, last visit. Every participant has completed their final visit or been formally discontinued, with any required follow-up done.

2. Data completion and cleaning. All data entered, all queries answered, all investigator sign-offs applied.

3. Database lock. The sponsor freezes the data. After lock, changes require a formal process.

4. Investigational product reconciliation. Every unit accounted for: received, dispensed, returned, destroyed or sent back. The numbers must reconcile, and any discrepancy must be explained.

5. Sample and supply disposition. Remaining laboratory kits, devices and materials returned or destroyed as instructed, with records.

6. Final safety reconciliation. Adverse events in the EDC system and in the sponsor's safety database agree.

7. Notifications. The ethics committee is told the study has ended at your site, in the timeframe local rules require. Where required, the investigator provides a summary of the outcome.

8. Essential records completed and archived. Everything filed, indexed, and stored so it can be retrieved and read.

9. The close-out visit. The monitor confirms all of the above and documents it.

Early termination

Studies sometimes stop before they were meant to: a safety signal, a business decision, poor recruitment, or a site being closed.

Extra obligations apply.

Handle the participant conversations first. They are the part that cannot be caught up later.

Archiving

E6(R3) Appendix C sets the expectations for essential records, and several are practical.

Electronic records need a specific decision that sites routinely forget: the audit trails in your systems are relevant metadata and therefore part of the essential records. Confirm with the sponsor how they will remain retrievable and readable for the whole retention period, and file that confirmation.

How long to retain

ICH E6(R3) states no retention period in years.

So the answer is never a number you remember. It is the sponsor's written instruction for this trial, filed where the next person will find it, and a named person responsible.

Never destroy trial records without written confirmation.

Telling participants what happened

Many participants ask what the study found. Sponsors increasingly provide a plain-language summary, and in some jurisdictions this is required. Ask the sponsor for one, and give it to the people who gave you their data. It costs almost nothing and it is one reason they will take part again.

In practice

VT-201 closes at Northside Clinic. Nadia works through the checklist and hits four questions.

Do we still need the paper consent forms now that they are scanned? Only if the scans are certified copies. The institution's system generates them through a validated process, so they qualify — but the sponsor's written instruction says keep the paper too. The paper stays.

The essential records table lists an independent data monitoring committee charter and we do not have one. VT-201 had a committee, but the charter was a sponsor record, not a site record. She notes the reason in the site's content list rather than leaving a gap.

How long do we keep everything? She finds the sponsor's written retention instruction in the site file. She does not use the number a colleague remembers from another study.

Who owns the archive after I leave? She names the institution's research records manager, tells the sponsor in writing, and files the confirmation.

She also confirms with Vantis Pharma how the EDC audit trails will remain readable for the full period, and where that arrangement is recorded.

If you cannot retrieve it and read it, you have not retained it.

Key takeaways